R P Polisson
Overview
Explore the profile of R P Polisson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
593
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Merkel P, Silliman N, Clements P, Denton C, Furst D, Mayes M, et al.
Arthritis Rheum
. 2012 Feb;
64(10):3420-9.
PMID: 22328195
Objective: To examine the range and responsiveness to change of clinical outcome measures and study predictors of clinical response in patients with diffuse cutaneous systemic sclerosis (dcSSc) in the context...
2.
Merkel P, Chang Y, Pierangeli S, Harris E, Polisson R
J Rheumatol
. 1999 Mar;
26(3):591-6.
PMID: 10090168
Objective: Antiphospholipid (aPL) antibodies are present in patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibody syndrome (APS) and are associated with recurrent thromboses, thrombocytopenia, and pregnancy losses. The presence...
3.
Williams H, Alarcon G, Neuner R, Steen V, Bulpitt K, Clegg D, et al.
J Rheumatol
. 1998 Mar;
25(2):261-8.
PMID: 9489817
Objective: To review the diagnoses after 5 years in patients who were identified within 12 months of the onset of well established and undifferentiated connective tissue diseases (CTD); to examine...
4.
Phillips A, Polisson R
Am J Med
. 1998 Feb;
103(6A):7S-11S.
PMID: 9455963
The differentiation of articular from nonarticular complaints and inflammatory from noninflammatory disorders can usually be made by clinical evaluation. Laboratory and radiographic studies serve as adjuncts in the evaluation of...
5.
GOODMAN T, Merkel P, Perlmutter G, Doyle M, Krane S, Polisson R
Arthritis Rheum
. 1997 Oct;
40(9):1619-27.
PMID: 9324016
Objective: Heterotopic ossification (HO) is a disorder characterized by the formation of new bone in tissue that does not ossify under normal conditions. We report a series of 6 cases...
6.
Merkel P, Polisson R, Chang Y, Skates S, Niles J
Ann Intern Med
. 1997 Jun;
126(11):866-73.
PMID: 9163287
Background: Two types of antineutrophil cytoplasmic antibodies (ANCA), antiproteinase 3 antibodies (anti-PR3) and antimyeloperoxidase antibodies (anti-MPO), are useful in the diagnosis of such types of vasculitis as Wegener granulomatosis and...
7.
Phillips A, Polisson R, Simon L
Drugs Aging
. 1997 Feb;
10(2):119-30.
PMID: 9061269
Despite their propensity to cause toxicity, nonsteroidal anti-inflammatory drugs (NSAIDs) are routinely prescribed for older patients for painful musculoskeletal conditions, many of which are noninflammatory in nature. In some settings,...
8.
Merkel P, Chang Y, Pierangeli S, Convery K, Harris E, Polisson R
Am J Med
. 1996 Dec;
101(6):576-83.
PMID: 9003103
Purpose: To determine the prevalence and clinical associations of anticardiolipin antibodies (aCL) in a blinded, controlled study of patients with a variety of connective tissue diseases (CTD) using a standardized...
9.
Merkel P, Dooley M, Dawson D, Pisetsky D, Polisson R
J Rheumatol
. 1996 Nov;
23(11):1856-61.
PMID: 8923356
Objective: To evaluate the associations of soluble serum interleukin-2 receptor (sIL-2R) levels in patients with rheumatoid arthritis (RA) with clinical and laboratory measures of disease activity and the predicted response...
10.
Polisson R, Gilkeson G, Pyun E, Pisetsky D, Smith E, Simon L
J Rheumatol
. 1996 Apr;
23(4):654-8.
PMID: 8730122
Objective: To evaluate the acute toxicity, potential efficacy, and effects on the soluble interleukin 2 receptor (sIL-2R) of recombinant human interferon gamma (rIFN-gamma) in patients with systemic sclerosis (SSc). Methods:...